1-2 of 2
Yaron R. Hadari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers

Jacqueline F. Doody, Ying Wang, Sheetal N. Patel, Christopher Joynes, Sui Ping Lee, Jason Gerlak, Robin L. Rolser, Yanxia Li, Philipp Steiner, Rajiv Bassi, Dan J. Hicklin, Yaron R. Hadari
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2642–2651.
https://doi.org/10.1158/1535-7163.MCT-06-0506
Published: 15 October 2007
View article titled, Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers
Open the PDF for Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non–small cell lung cancers in another window
Journal Articles

Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation

Keren Paz, Laura A. Brennan, Michelle Iacolina, Jacqueline Doody, Yaron R. Hadari, Zhenping Zhu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (11): 1801–1809.
https://doi.org/10.1158/1535-7163.MCT-05-0174
Published: 07 November 2005
View article titled, Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation
Open the PDF for Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation in another window